Mitsubishi UFJ Asset Management (UK)’s Amedisys AMED Stock Holding History

Mitsubishi UFJ Asset Management (UK)’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,800	Closed	-$234K	–	91
2022 Q4	$234K	Hold	2,800	–	–	0.16%	78
2022 Q3	$271K	Hold	2,800	–	–	0.21%	74
2022 Q2	$294K	Hold	2,800	–	–	0.17%	80
2022 Q1	$482K	Buy	+2,800	New	+$418K	0.22%	90
2020 Q4	–	Sell	-5,700	Closed	-$1.35M	–	78
2020 Q3	$1.35M	Buy	5,700 +500	+10%	+$114K	0.66%	47
2020 Q2	$1.03M	Hold	5,200	–	–	0.55%	57
2020 Q1	$954K	Sell	5,200 -3,000	-37%	-$534K	0.71%	53
2019 Q4	$1.37M	Hold	8,200	–	–	0.55%	52
2019 Q3	$1.07M	Hold	8,200	–	–	0.5%	51
2019 Q2	$996	Hold	8,200	–	–	0.01%	64
2019 Q1	$1.01K	Buy	+8,200	New	+$1.03M	0.01%	58
2018 Q4	–	Sell	-8,700	Closed	-$1.09K	–	76
2018 Q3	$1.09K	Sell	8,700 -5,000	-36%	-$552K	0.03%	69
2018 Q2	$1.17M	Buy	13,700 +4,500	+49%	+$330K	0.66%	49
2018 Q1	$555K	Sell	9,200 -13,000	-59%	-$740K	0.37%	70
2017 Q4	$1.17M	Buy	22,200 +3,000	+16%	+$158K	0.84%	49
2017 Q3	$1.07M	Hold	19,200	–	–	0.84%	50
2017 Q2	$1.21M	Buy	+19,200	New	+$1.12M	1.07%	46

Other funds holding AMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Mitsubishi UFJ Asset Management (UK)'s AMED Position: Q1 2023 in Review

Mitsubishi UFJ Asset Management (UK) sold out of Amedisys (AMED) in Q1 2023, closing a stake of 2,800 shares — an estimated $234K sold.

Mitsubishi UFJ Asset Management (UK) first reported a position in AMED in Q2 2017 and held it in 17 quarters. The position peaked at $1.37M in Q4 2019. 281 funds tracked by Wall St. Rank hold AMED as of Q1 2023.

Mitsubishi UFJ Asset Management (UK) reported no remaining Amedisys position as of Q1 2023 after selling out during the quarter.
Mitsubishi UFJ Asset Management (UK) sold 2,800 Amedisys shares in Q1 2023, an estimated $234K.
Mitsubishi UFJ Asset Management (UK) first reported a position in Amedisys in Q2 2017 and held it in 17 quarters.
Mitsubishi UFJ Asset Management (UK)'s Amedisys position peaked at $1.37M in Q4 2019.
281 funds tracked by Wall St. Rank held Amedisys as of Q1 2023.

Based on Mitsubishi UFJ Asset Management (UK)'s 13F filing for Q1 2023, filed 2 May 2023.